Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by Laura R  – Israel, 2020-03-22 09:58 (1936 d 04:17 ago) – Posting: # 21294
Views: 5,821

Hi, was wondering how P1 CROs are dealing with the COVID19 crisis, and if there is any chance to keep studies moving (in small cohorts, no overnight stays, etc).
Should HV studies considered an essential activity per the new FDA/EMA guidances, is voluteering in a Phase 1 study considered a valid reason to be outside? Laura

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,682 registered users;
61 visitors (0 registered, 61 guests [including 13 identified bots]).
Forum time: 15:15 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5